Literature DB >> 33044226

Landscape of coordinated immune responses to H1N1 challenge in humans.

Zainab Rahil1,2, Rebecca Leylek2, Christian M Schürch1,2, Han Chen1,2, Zach Bjornson-Hooper1,2, Shannon R Christensen3, Pier Federico Gherardini4, Salil S Bhate1,2,5, Matthew H Spitzer6, Gabriela K Fragiadakis7, Nilanjan Mukherjee1,2, Nelson Kim1,2, Sizun Jiang1,2, Jennifer Yo8, Brice Gaudilliere9, Melton Affrime10, Bonnie Bock10, Scott E Hensley3, Juliana Idoyaga2, Nima Aghaeepour9, Kenneth Kim8, Garry P Nolan1,2, David R McIlwain1,2,10.   

Abstract

Influenza is a significant cause of morbidity and mortality worldwide. Here we show changes in the abundance and activation states of more than 50 immune cell subsets in 35 individuals over 11 time points during human A/California/2009 (H1N1) virus challenge monitored using mass cytometry along with other clinical assessments. Peak change in monocyte, B cell, and T cell subset frequencies coincided with peak virus shedding, followed by marked activation of T and NK cells. Results led to the identification of CD38 as a critical regulator of plasmacytoid dendritic cell function in response to influenza virus. Machine learning using study-derived clinical parameters and single-cell data effectively classified and predicted susceptibility to infection. The coordinated immune cell dynamics defined in this study provide a framework for identifying novel correlates of protection in the evaluation of future influenza therapeutics.

Entities:  

Keywords:  Adaptive immunity; Immunology; Infectious disease; Influenza; Innate immunity

Mesh:

Year:  2020        PMID: 33044226      PMCID: PMC7598057          DOI: 10.1172/JCI137265

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.

Authors:  T Vaisitti; S Aydin; D Rossi; F Cottino; L Bergui; G D'Arena; L Bonello; A L Horenstein; P Brennan; C Pepper; G Gaidano; F Malavasi; S Deaglio
Journal:  Leukemia       Date:  2010-03-11       Impact factor: 11.528

Review 2.  Emergency granulopoiesis.

Authors:  Markus G Manz; Steffen Boettcher
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

3.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

4.  Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm.

Authors:  Eli R Zunder; Rachel Finck; Gregory K Behbehani; El-Ad D Amir; Smita Krishnaswamy; Veronica D Gonzalez; Cynthia G Lorang; Zach Bjornson; Matthew H Spitzer; Bernd Bodenmiller; Wendy J Fantl; Dana Pe'er; Garry P Nolan
Journal:  Nat Protoc       Date:  2015-01-22       Impact factor: 13.491

5.  STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

Authors:  Sean A Diehl; Heike Schmidlin; Maho Nagasawa; Simon D van Haren; Mark J Kwakkenbos; Etsuko Yasuda; Tim Beaumont; Ferenc A Scheeren; Hergen Spits
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

6.  Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.

Authors:  Jean-François Fonteneau; Michel Gilliet; Marie Larsson; Ida Dasilva; Christian Münz; Yong-Jun Liu; Nina Bhardwaj
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

7.  Systems biology of vaccination for seasonal influenza in humans.

Authors:  Helder I Nakaya; Jens Wrammert; Eva K Lee; Luigi Racioppi; Stephanie Marie-Kunze; W Nicholas Haining; Anthony R Means; Sudhir P Kasturi; Nooruddin Khan; Gui-Mei Li; Megan McCausland; Vibhu Kanchan; Kenneth E Kokko; Shuzhao Li; Rivka Elbein; Aneesh K Mehta; Alan Aderem; Kanta Subbarao; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2011-07-10       Impact factor: 25.606

8.  M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.

Authors:  Suzanne L Cole; Jake Dunning; Wai Ling Kok; Kambez Hajipouran Benam; Adel Benlahrech; Emmanouela Repapi; Fernando O Martinez; Lydia Drumright; Timothy J Powell; Michael Bennett; Ruth Elderfield; Catherine Thomas; Tao Dong; John McCauley; Foo Y Liew; Stephen Taylor; Maria Zambon; Wendy Barclay; Vincenzo Cerundolo; Peter J Openshaw; Andrew J McMichael; Ling-Pei Ho
Journal:  JCI Insight       Date:  2017-04-06

Review 9.  Influenza.

Authors:  Florian Krammer; Gavin J D Smith; Ron A M Fouchier; Malik Peiris; Katherine Kedzierska; Peter C Doherty; Peter Palese; Megan L Shaw; John Treanor; Robert G Webster; Adolfo García-Sastre
Journal:  Nat Rev Dis Primers       Date:  2018-06-28       Impact factor: 52.329

10.  Innate immune sensing and response to influenza.

Authors:  Bali Pulendran; Mohan S Maddur
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

View more
  7 in total

1.  Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.

Authors:  David R McIlwain; Han Chen; Zainab Rahil; Neda Hajiakhoond Bidoki; Sizun Jiang; Zach Bjornson; Nikita S Kolhatkar; C Josefina Martinez; Brice Gaudillière; Julien Hedou; Nilanjan Mukherjee; Christian M Schürch; Angelica Trejo; Melton Affrime; Bonnie Bock; Kenneth Kim; David Liebowitz; Nima Aghaeepour; Sean N Tucker; Garry P Nolan
Journal:  Cell Host Microbe       Date:  2021-11-15       Impact factor: 21.023

Review 2.  Human Innate Lymphoid Cells in Influenza Infection and Vaccination.

Authors:  Amrita Kumar; Rashmi Kumari; Timothy Liu; Weiping Cao; Bruce A Davidson; Paul R Knight; Suryaprakash Sambhara
Journal:  Crit Rev Immunol       Date:  2021       Impact factor: 1.735

3.  The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.

Authors:  Marios Koutsakos; Wen Shi Lee; Arnold Reynaldi; Hyon-Xhi Tan; Grace Gare; Paul Kinsella; Kwee Chin Liew; George Taiaroa; Deborah A Williamson; Helen E Kent; Eva Stadler; Deborah Cromer; David S Khoury; Adam K Wheatley; Jennifer A Juno; Miles P Davenport; Stephen J Kent
Journal:  Immunity       Date:  2022-05-27       Impact factor: 43.474

4.  A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection.

Authors:  Elizabeth E McCarthy; Pamela M Odorizzi; Emma Lutz; Carolyn P Smullin; Iliana Tenvooren; Mars Stone; Graham Simmons; Peter W Hunt; Margaret E Feeney; Philip J Norris; Michael P Busch; Matthew H Spitzer; Rachel L Rutishauser
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

5.  Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.

Authors:  Dorien Feyaerts; Julien Hedou; Joshua Gillard; Han Chen; Eileen S Tsai; Laura S Peterson; Kazuo Ando; Monali Manohar; Evan Do; Gopal K R Dhondalay; Jessica Fitzpatrick; Maja Artandi; Iris Chang; Theo T Snow; R Sharon Chinthrajah; Christopher M Warren; Rich Wittman; Justin G Meyerowitz; Edward A Ganio; Ina A Stelzer; Xiaoyuan Han; Franck Verdonk; Dyani K Gaudilliere; Nilanjan Mukherjee; Amy S Tsai; Kristen K Rumer; Sizun J Jiang; Sergio I Valdes-Ferrer; J Daniel Kelly; David Furman; Nima Aghaeepour; Martin S Angst; Scott D Boyd; Benjamin A Pinsky; Garry P Nolan; Kari C Nadeau; Brice Gaudilliere; David R McIlwain
Journal:  bioRxiv       Date:  2021-02-10

6.  Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE.

Authors:  Marie Burns; Lennard Ostendorf; Robert Biesen; Andreas Grützkau; Falk Hiepe; Henrik E Mei; Tobias Alexander
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

7.  Variation of Immune Cell Responses in Humans Reveals Sex-Specific Coordinated Signaling Across Cell Types.

Authors:  Gabriela K Fragiadakis; Zachary B Bjornson-Hooper; Deepthi Madhireddy; Karen Sachs; Han Chen; David R McIlwain; Matthew H Spitzer; Sean C Bendall; Garry P Nolan
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.